Collegium Pharmaceutical Quarterly Income Statements Chart
Quarterly
|
Annual
Collegium Pharmaceutical Quarterly Income Statements Table
Quarterly
|
Annual
| Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| product revenues | 188,000,000 | 177,757,000 | 181,949,000 | 159,301,000 | 145,276,000 | 144,923,000 | 149,745,000 | 136,709,000 | 135,546,000 | 144,767,000 | 129,620,000 | 127,013,000 | 123,549,000 | 83,751,000 | 27,362,000 | 78,843,000 | 82,942,000 | 87,721,000 | 76,271,000 | 79,176,000 | 78,058,000 | 76,511,000 | 74,203,000 | 72,942,000 | 75,040,000 | 74,516,000 | 73,427,000 | 70,176,000 | 73,061,000 | 63,749,000 | 10,794,000 | 11,950,000 | 3,560,000 | 2,172,000 | 1,303,000 | 408,000 | ||||||
| cost of product revenues | 24,143,000 | 24,960,000 | 28,190,000 | 21,706,000 | 19,955,000 | 18,950,000 | 20,601,000 | 20,081,000 | 24,257,000 | 29,899,000 | 37,552,000 | 30,622,000 | 33,684,000 | 16,332,000 | 11,900,000 | 15,934,000 | 15,908,000 | 15,328,000 | 15,184,000 | 14,188,000 | 12,899,000 | 27,229,000 | 49,088,000 | 46,754,000 | 48,654,000 | 49,164,000 | 29,726,000 | 46,007,000 | 46,838,000 | 43,106,000 | 1,094,000 | 553,000 | 577,000 | 371,000 | 184,000 | 29,000 | ||||||
| intangible asset amortization | 55,473,000 | 55,473,000 | 27,458,250 | 40,801,000 | 34,515,000 | 34,517,000 | 27,811,500 | 36,317,000 | 37,463,000 | 37,466,000 | 23,494,000 | 37,552,000 | 37,501,000 | 18,923,000 | 16,795,000 | 16,796,000 | 16,795,000 | 16,795,000 | 16,795,000 | 16,795,000 | 16,795,000 | 10,295,000 | ||||||||||||||||||||
| total cost of product revenues | 79,616,000 | 80,433,000 | 42,611,000 | 62,507,000 | 54,470,000 | 53,467,000 | 46,370,750 | 56,398,000 | ||||||||||||||||||||||||||||||||||
| gross profit | 108,384,000 | 97,324,000 | 98,288,000 | 96,794,000 | 90,806,000 | 91,456,000 | 94,630,000 | 80,311,000 | 73,826,000 | 77,402,000 | 49,789,000 | 58,839,000 | 52,364,000 | 48,496,000 | -1,333,000 | 46,113,000 | 50,239,000 | 55,598,000 | 44,292,000 | 48,193,000 | 48,364,000 | 38,987,000 | ||||||||||||||||||||
| yoy | 19.36% | 6.42% | 3.87% | 20.52% | 23.00% | 18.16% | 90.06% | 36.49% | 40.99% | 59.60% | -3835.11% | 27.60% | 4.23% | -12.77% | -103.01% | -4.32% | 3.88% | 42.61% | ||||||||||||||||||||||||
| qoq | 11.36% | -0.98% | 1.54% | 6.59% | -0.71% | -3.35% | 17.83% | 8.78% | -4.62% | 55.46% | -15.38% | 12.37% | 7.98% | -3738.11% | -102.89% | -8.21% | -9.64% | 25.53% | -8.09% | -0.35% | 24.05% | |||||||||||||||||||||
| gross margin % | ||||||||||||||||||||||||||||||||||||||||||
| operating expenses | ||||||||||||||||||||||||||||||||||||||||||
| selling, general and administrative | 73,637,000 | 76,423,000 | 63,091,000 | 61,955,000 | 43,335,000 | 41,982,000 | 32,942,000 | 35,298,000 | 38,193,000 | 52,775,000 | 38,032,000 | 38,372,000 | 41,254,000 | 54,528,000 | 26,602,000 | 30,514,000 | 30,368,000 | 31,476,000 | 26,824,000 | 26,426,000 | 29,322,000 | 31,260,000 | 25,090,000 | 30,072,000 | 28,935,000 | 32,352,000 | 30,451,000 | 33,448,000 | 31,279,000 | 31,582,000 | 25,089,000 | 22,758,000 | 22,062,000 | 22,847,000 | 25,366,000 | 23,567,000 | 20,173,000 | 11,525,000 | ||||
| gain on fair value remeasurement of contingent consideration | -358,000 | -786,000 | ||||||||||||||||||||||||||||||||||||||||
| total operating expenses | 73,279,000 | 75,637,000 | 60,177,000 | 61,955,000 | 43,335,000 | 41,982,000 | 32,942,000 | 35,298,000 | 38,193,000 | 52,775,000 | 38,032,000 | 38,372,000 | 41,254,000 | 58,511,000 | 32,789,000 | 31,964,000 | 33,830,000 | 34,406,000 | 29,296,000 | 28,567,000 | 31,815,000 | 33,926,000 | 24,474,000 | 15,587,000 | 9,436,000 | 9,265,000 | 4,575,000 | 3,630,000 | ||||||||||||||
| income from operations | 35,105,000 | 21,687,000 | 38,111,000 | 34,839,000 | 47,471,000 | 49,474,000 | 61,688,000 | 45,013,000 | 35,633,000 | 24,627,000 | 11,757,000 | 20,467,000 | 11,110,000 | -10,015,000 | -34,122,000 | 14,149,000 | 16,409,000 | 21,192,000 | 14,996,000 | 19,626,000 | 16,549,000 | 5,061,000 | -2,373,000 | -6,375,000 | -5,008,000 | -9,992,000 | 11,001,000 | -11,186,000 | -7,293,000 | -13,207,000 | -17,583,000 | -13,430,000 | -21,258,000 | -23,176,000 | -27,578,000 | -26,442,000 | -24,474,000 | -15,587,000 | -9,436,000 | -9,265,000 | ||
| yoy | -26.05% | -56.16% | -38.22% | -22.60% | 33.22% | 100.89% | 424.69% | 119.93% | 220.73% | -345.90% | -134.46% | 44.65% | -32.29% | -147.26% | -327.54% | -27.91% | -0.85% | 318.73% | -731.94% | -407.86% | -430.45% | -150.65% | -121.57% | -43.01% | -31.33% | -24.34% | -162.57% | -16.71% | -65.69% | -43.01% | -36.24% | -49.21% | -13.14% | 48.69% | 192.26% | 185.40% | ||||||
| qoq | 61.87% | -43.10% | 9.39% | -26.61% | -4.05% | -19.80% | 37.04% | 26.32% | 44.69% | 109.47% | -42.56% | 84.22% | -210.93% | -70.65% | -341.16% | -13.77% | -22.57% | 41.32% | -23.59% | 18.59% | 226.99% | -313.27% | -62.78% | 27.30% | -49.88% | -190.83% | -198.35% | 53.38% | -44.78% | -24.89% | 30.92% | -36.82% | -8.28% | -15.96% | 4.30% | 8.04% | 57.02% | 65.19% | 1.85% | |||
| operating margin % | ||||||||||||||||||||||||||||||||||||||||||
| interest expense | -20,463,000 | -20,790,000 | -22,654,000 | -18,394,000 | -15,587,000 | -17,339,000 | -19,281,000 | -20,768,000 | -21,863,000 | -21,427,000 | -20,575,000 | -19,046,000 | -17,761,000 | -5,831,000 | -4,757,000 | -5,115,000 | -5,421,000 | -5,721,000 | -7,737,000 | -8,063,000 | -8,259,000 | -4,823,000 | -211,000 | -228,000 | -236,000 | -234,000 | -2,404,000 | -5,868,000 | -6,158,000 | -5,700,000 | -19,000 | 2,000 | 46,000 | 66,000 | 89,000 | 97,000 | 99,000 | 155,000 | ||||
| interest income | 2,383,000 | 2,225,000 | 1,812,000 | 3,280,000 | 4,397,000 | 4,487,000 | 4,303,000 | 4,538,000 | 4,027,000 | 2,747,000 | 1,027,000 | 11,000 | 5,000 | 4,000 | 3,000 | 3,000 | 3,000 | 3,000 | 3,000 | 3,000 | 14,000 | 212,000 | 383,000 | 494,000 | 532,000 | 526,000 | 489,000 | 552,000 | 391,000 | 255,000 | 180,000 | 167,000 | 137,000 | 98,000 | ||||||||
| loss on extinguishment of debt | -4,145,000 | -7,184,000 | -23,504,000 | |||||||||||||||||||||||||||||||||||||||
| income before income taxes | 17,025,000 | 3,122,000 | 17,269,000 | 15,580,000 | 29,097,000 | 36,622,000 | 46,710,000 | 28,783,000 | 17,797,000 | -17,557,000 | -7,791,000 | 1,432,000 | -6,646,000 | -15,842,000 | -38,876,000 | 9,037,000 | 10,991,000 | 15,474,000 | 7,262,000 | 11,566,000 | 8,304,000 | |||||||||||||||||||||
| benefit from income taxes | 5,042,000 | 705,000 | 4,733,000 | 6,245,000 | 9,491,000 | 8,909,000 | 14,770,000 | 8,149,000 | 4,790,000 | -131,000 | -813,250 | 975,000 | -1,455,000 | -15,262,250 | 991,000 | -188,000 | 304,000 | 280,000 | 246,000 | |||||||||||||||||||||||
| net income | 11,983,000 | 2,417,000 | 12,536,000 | 9,335,000 | 19,606,000 | 27,713,000 | 31,940,000 | 20,634,000 | 13,007,000 | -17,426,000 | -7,199,000 | 457,000 | -5,191,000 | -13,069,000 | -25,034,000 | 8,046,000 | 72,843,000 | 15,662,000 | 6,958,000 | 11,286,000 | 8,058,000 | 450,000 | -2,201,000 | -6,109,000 | -4,712,000 | -9,700,000 | 9,086,000 | -16,502,000 | -13,060,000 | -18,652,000 | -17,403,000 | -13,263,000 | -21,121,000 | -23,078,000 | -24,520,000 | -15,653,000 | -9,525,000 | -9,362,000 | -4,674,000 | -3,694,000 | ||
| yoy | -38.88% | -91.28% | -60.75% | -54.76% | 50.73% | -259.03% | -543.67% | 4415.10% | -350.57% | 33.34% | -71.24% | -94.32% | -107.13% | -183.44% | -459.79% | -28.71% | 803.98% | 3380.44% | -416.13% | -284.74% | -271.01% | -104.64% | -124.22% | -62.98% | -63.92% | -47.99% | -152.21% | 24.42% | -38.17% | -19.18% | -13.86% | 47.43% | 424.60% | 323.74% | ||||||||
| qoq | 395.78% | -80.72% | 34.29% | -52.39% | -29.25% | -13.23% | 54.79% | 58.64% | -174.64% | 142.06% | -1675.27% | -108.80% | -60.28% | -47.79% | -411.14% | -88.95% | 365.09% | 125.09% | -38.35% | 40.06% | 1690.67% | -120.45% | -63.97% | 29.65% | -51.42% | -206.76% | -155.06% | 26.36% | -29.98% | 7.18% | 31.21% | -37.20% | -8.48% | 56.65% | 64.34% | 1.74% | 100.30% | 26.53% | ||||
| net income margin % | ||||||||||||||||||||||||||||||||||||||||||
| | ||||||||||||||||||||||||||||||||||||||||||
| earnings per share — basic | 0.38 | 0.08 | 0.39 | 0.29 | 0.6 | 0.86 | 0.96 | 0.61 | 0.38 | -0.22 | 0.01 | -0.15 | -0.39 | -0.69 | 0.23 | 2.06 | 0.45 | 0.2 | 0.33 | 0.23 | 0.01 | |||||||||||||||||||||
| weighted-average shares — basic | 31,810,612 | 31,793,739 | 32,273,850 | 32,259,468 | 32,433,025 | 32,326,589 | 33,741,213 | 33,744,209 | 34,622,284 | 34,319,291 | 33,829,495 | 34,058,802 | 34,001,553 | 33,673,912 | 34,936,817 | 35,373,909 | 35,302,608 | 34,951,740 | 34,407,959 | 34,540,126 | 34,395,266 | 34,100,688 | ||||||||||||||||||||
| earnings per share — diluted | 0.34 | 0.07 | 0.35 | 0.27 | 0.52 | 0.71 | 0.83 | 0.53 | 0.34 | -0.22 | 0.01 | -0.15 | -0.39 | -0.56 | 0.22 | 1.79 | 0.41 | 0.2 | 0.32 | 0.23 | 0.01 | |||||||||||||||||||||
| weighted-average shares — diluted | 39,075,703 | 32,840,153 | 40,424,180 | 40,163,266 | 40,383,694 | 41,438,466 | 41,788,125 | 42,058,821 | 42,849,952 | 34,319,291 | 33,829,495 | 34,570,319 | 34,001,553 | 33,673,912 | 41,045,805 | 36,261,174 | 41,286,853 | 41,160,092 | 35,151,353 | 35,069,188 | 35,091,906 | 35,069,693 | ||||||||||||||||||||
| research and development | 3,983,000 | 1,609,000 | 1,450,000 | 3,462,000 | 2,930,000 | 2,472,000 | 2,141,000 | 2,493,000 | 2,666,000 | 2,398,000 | 2,491,000 | 2,459,000 | 2,992,000 | 2,249,000 | 1,907,000 | 2,237,000 | 2,268,000 | 2,194,000 | 2,069,000 | 2,179,000 | 2,130,000 | 3,331,000 | 3,254,000 | 4,301,000 | 4,062,000 | 1,531,000 | 3,358,000 | 1,641,000 | 1,445,000 | |||||||||||||
| total cost of products revenues | 61,720,000 | 67,365,000 | 79,831,000 | 68,174,000 | 71,185,000 | 35,255,000 | 28,695,000 | 32,730,000 | 32,703,000 | 32,123,000 | 31,979,000 | 30,983,000 | 29,694,000 | 37,524,000 | ||||||||||||||||||||||||||||
| loss per share — basic | -0.51 | |||||||||||||||||||||||||||||||||||||||||
| loss per share — diluted | -0.51 | |||||||||||||||||||||||||||||||||||||||||
| (benefit from) benefit from income taxes | -2,773,000 | -61,852,000 | ||||||||||||||||||||||||||||||||||||||||
| costs and expenses | ||||||||||||||||||||||||||||||||||||||||||
| total costs and expenses | 76,576,000 | 79,317,000 | 80,048,000 | 84,508,000 | 62,426,000 | 81,362,000 | 80,354,000 | 76,956,000 | 28,377,000 | 25,380,000 | 24,818,000 | 25,348,000 | 28,881,000 | 26,850,000 | ||||||||||||||||||||||||||||
| loss per share - basic and diluted | -0.06 | -0.18 | -0.14 | -0.29 | 0.27 | -0.5 | -0.4 | -0.57 | -0.488 | -0.45 | -0.72 | -0.79 | -0.713 | -1.13 | ||||||||||||||||||||||||||||
| weighted-average shares - basic and diluted | 33,453,844 | 33,481,923 | 33,397,709 | 33,331,917 | 32,953,808 | 33,012,174 | 32,967,718 | 32,903,674 | 29,753,043 | 29,441,514 | 29,350,268 | 23,460,340 | 23,417,378 | |||||||||||||||||||||||||||||
| other income | ||||||||||||||||||||||||||||||||||||||||||
| total other income | 98,000 | 28,250 | 2,000 | 46,000 | 66,000 | 89,000 | 97,000 | 99,000 | 64,000 | |||||||||||||||||||||||||||||||||
| gain on extinguishment of debt | ||||||||||||||||||||||||||||||||||||||||||
| net and comprehensive loss | -16,654,250 | -26,444,000 | ||||||||||||||||||||||||||||||||||||||||
| operating expenses: | ||||||||||||||||||||||||||||||||||||||||||
| other income: | ||||||||||||||||||||||||||||||||||||||||||
| earnings per share - basic and diluted | -1.05 | |||||||||||||||||||||||||||||||||||||||||
| earnings per share - basic | -0.68 | |||||||||||||||||||||||||||||||||||||||||
| earnings per share - diluted | -0.68 | |||||||||||||||||||||||||||||||||||||||||
| weighted-average shares - basic | 23,130,153 | |||||||||||||||||||||||||||||||||||||||||
| weighted-average shares - diluted | 23,130,153 | |||||||||||||||||||||||||||||||||||||||||
| general and administrative | 7,905,000 | 5,907,000 | 2,934,000 | 2,185,000 | ||||||||||||||||||||||||||||||||||||||
| gain on extinguishment | -22,750 | |||||||||||||||||||||||||||||||||||||||||
| net income per share | -0.54 | -0.46 | -0.45 | |||||||||||||||||||||||||||||||||||||||
| weighted-average number of common shares used in net income per share-basic and diluted | 13,542,282 | 20,531,406 | 11,791,546 | |||||||||||||||||||||||||||||||||||||||
| earning (loss) per share-basic | 0.34 | |||||||||||||||||||||||||||||||||||||||||
| earnings per share-diluted | -0.65 | |||||||||||||||||||||||||||||||||||||||||
| weighted-average shares-basic | 1,001,704 | |||||||||||||||||||||||||||||||||||||||||
| weighted-average shares-diluted | 7,554,524 |
We provide you with 20 years income statements for Collegium Pharmaceutical stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Collegium Pharmaceutical stock. Explore the full financial landscape of Collegium Pharmaceutical stock with our expertly curated income statements.
The information provided in this report about Collegium Pharmaceutical stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.